Usage: AZOPT is indicated for treating elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma as a carbonic anhydrase inhibitor.
Usage: BETOPTIC S® (betaxolol hydrochloride) 0.25% is indicated for reducing elevated intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.
Usage: BETOPTIC S (betaxolol hydrochloride ophthalmic suspension) 0.25% is indicated for lowering elevated intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.
(betaxolol hydrochloride and pilocarpine hydrochloride)
Manufacturer:Alcon Laboratories Inc
Usage: Betoptic® Pilo Ophthalmic Suspension is indicated for reducing elevated intraocular pressure in patients with primary open-angle glaucoma and ocular hypertension who do not adequately respond to Betoptic®-S. Its efficacy compared to separate Betoptic®-S and pilocarpine, or other beta-blockers with pilocarpine, is not established.
Usage: Bimatoprost ophthalmic solution, 0.03%, is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Usage: Bimatoprost ophthalmic solution 0.03% is indicated for lowering elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Usage: Bimatoprost ophthalmic solution, 0.03% is indicated for lowering elevated intraocular pressure in individuals with open angle glaucoma or ocular hypertension.
Usage: Bimatoprost ophthalmic solution, 0.03%, is indicated for lowering elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Usage: Brimonidine tartrate ophthalmic solution is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.